Exploring IDEAYA Biosciences, Inc. (IDYA) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind IDEAYA Biosciences, Inc. (IDYA), and what motivates their investment decisions? As of November 2024, institutional investors hold a significant 110.14% of the company's shares, while mutual funds hold 83.37%.

IDEAYA Biosciences, Inc. (IDYA) Who Invests in IDEAYA Biosciences, Inc. (IDYA) and Why?

Understanding the investor profile of IDEAYA Biosciences, Inc. (IDYA) involves examining the various types of investors, their motivations, and the strategies they employ. This insight is crucial for current and potential investors looking to align their investment approach with the overall market sentiment towards IDYA. For further insights into the company's direction, explore Mission Statement, Vision, & Core Values of IDEAYA Biosciences, Inc. (IDYA).

Key Investor Types: The investor base of IDEAYA Biosciences, Inc. (IDYA) can be broadly categorized into retail investors, institutional investors, and hedge funds.

• Retail Investors: These are individual investors who buy and sell shares for their own accounts. Their investment decisions are often influenced by factors such as news, market trends, and personal financial goals.
• Institutional Investors: This category includes entities such as mutual funds, pension funds, and insurance companies that invest on behalf of their clients. Institutional investors typically have a longer-term investment horizon and conduct extensive research before investing.
• Hedge Funds: These are investment partnerships that use pooled funds and employ various strategies to generate returns. Hedge funds are known for their flexibility and ability to invest in a wide range of assets, including stocks, bonds, and derivatives.

Investment Motivations: Several factors attract investors to IDEAYA Biosciences, Inc. (IDYA), including its growth prospects, strategic market position, and potential for innovation in the biotechnology sector.

• Growth Prospects: Investors are drawn to IDEAYA Biosciences, Inc. (IDYA)'s potential for growth, driven by its pipeline of drug candidates and strategic collaborations. The company's focus on innovative therapies and its ability to secure funding for research and development are key factors influencing investor confidence.
• Market Position: IDEAYA Biosciences, Inc. (IDYA)'s position in the competitive biotechnology landscape is another important consideration. Investors assess the company's competitive advantages, such as its proprietary technologies, intellectual property portfolio, and partnerships with leading research institutions.

Investment Strategies: Investors in IDEAYA Biosciences, Inc. (IDYA) adopt various strategies based on their investment goals and risk tolerance.

• Long-Term Holding: Many institutional investors and some retail investors adopt a long-term holding strategy, focusing on the company's long-term potential and growth prospects. This approach involves holding shares for an extended period, typically several years, to benefit from the company's growth and value appreciation.
• Short-Term Trading: Some investors, particularly hedge funds and active traders, engage in short-term trading strategies to capitalize on short-term price fluctuations. This approach involves buying and selling shares within a shorter timeframe, often days or weeks, to generate profits from market volatility.
• Value Investing: Value investors seek to identify undervalued companies with strong fundamentals and growth potential. They may invest in IDEAYA Biosciences, Inc. (IDYA) if they believe the company's stock price is below its intrinsic value, based on factors such as its assets, earnings potential, and future prospects.

To provide a clearer picture, consider a hypothetical breakdown of IDEAYA Biosciences, Inc. (IDYA)'s investor composition:

IDEAYA Biosciences, Inc. (IDYA) Institutional Ownership and Major Shareholders of IDEAYA Biosciences, Inc. (IDYA)

Understanding the institutional ownership of IDEAYA Biosciences, Inc. (IDYA) can provide valuable insights into the company's stability and investor confidence. Institutional investors, which include mutual funds, hedge funds, pension funds, and other large entities, often have significant influence due to the size of their holdings. Here’s a detailed look at the major players and their impact on IDYA.

As of the latest filings, several institutional investors hold substantial positions in IDEAYA Biosciences, Inc. (IDYA). These large stakeholders can significantly influence the company’s stock price and strategic direction. Monitoring these investors' activities can offer clues about the future prospects of the company. Some of the top institutional investors include:

• Vanguard Group Inc.: Holding a significant number of shares, Vanguard is a major institutional investor in IDYA.
• BlackRock Fund Advisors: Another key player, BlackRock's investment reflects its confidence in the company's potential.
• State Street Global Advisors: With a substantial stake, State Street is an important institutional holder.
• Other Notable Firms: Additional firms like Geode Capital Management and Nikko Asset Management Americas Inc. also hold notable positions.

Examining the recent changes in ownership can reveal shifts in investor sentiment. Increases in institutional holdings may indicate growing confidence in IDEAYA Biosciences, Inc. (IDYA), while decreases could signal concerns about the company's future performance. For example:

• Recent filings may show that some institutions have increased their positions, indicating a bullish outlook.
• Conversely, some institutions may have reduced their stakes, possibly due to portfolio adjustments or concerns about specific risks.

The presence and actions of large institutional investors can have a profound impact on IDEAYA Biosciences, Inc. (IDYA). Their investment decisions can drive stock price movements and influence the company’s strategic decisions. Here’s how:

• Stock Price Stability: High institutional ownership can provide stability to the stock price, as these investors often have a long-term investment horizon.
• Strategic Influence: Large shareholders can influence corporate governance and strategic decisions through voting rights and direct engagement with management.
• Market Perception: The actions of prominent investors are closely watched by the market, and their decisions can impact overall investor sentiment towards IDEAYA Biosciences, Inc. (IDYA).

For additional details on IDEAYA Biosciences, Inc. (IDYA), you might find this resource helpful: IDEAYA Biosciences, Inc. (IDYA): History, Ownership, Mission, How It Works & Makes Money

Analyzing the trends in institutional ownership provides a deeper understanding of market confidence and potential future performance of IDEAYA Biosciences, Inc. (IDYA).

IDEAYA Biosciences, Inc. (IDYA) Key Investors and Their Impact on IDEAYA Biosciences, Inc. (IDYA)

Understanding the investor profile of IDEAYA Biosciences, Inc. (IDYA) is crucial for gauging market sentiment and potential stock movements. Key investors can significantly influence company decisions and stock performance through their holdings and strategic moves.

While specific, real-time details on all institutional and individual investors are constantly in flux, we can discuss the types of investors and their potential impact, along with examples of notable investors that may hold positions in biotech companies like IDEAYA Biosciences, Inc. (IDYA).

Here are potential types of investors and their possible influence:

• Hedge Funds: These funds often take large positions and can be involved in activist investing, pushing for changes in company strategy or management.
• Venture Capital Funds: Venture capital funds that previously invested in IDEAYA Biosciences, Inc. (IDYA) during its early stages may still hold significant stakes. Their actions can signal confidence or a need to divest.
• Institutional Investors: Mutual funds, pension funds, and insurance companies typically hold large blocks of shares. Their investment decisions are often based on in-depth research and can have a stabilizing effect on the stock price.
• Retail Investors: A large base of retail investors can increase stock volatility, especially if there is coordinated buying or selling activity through online forums.

Examples of moves by investors can include:

• Buying or Selling Large Stakes: Significant increases or decreases in ownership by major investors must be disclosed and can trigger immediate stock reactions.
• Activist Campaigns: Public campaigns by activist investors can lead to significant changes in corporate governance or strategic direction.
• Proxy Battles: Disputes among shareholders can lead to proxy battles, influencing the composition of the board of directors and company policies.

Keeping an eye on major institutional holders and any significant changes in their positions is a good start. Reviewing SEC filings (such as 13F filings for institutional investors) can provide insights into who the major players are and how their holdings have changed over time.

For further insights into IDEAYA Biosciences, Inc. (IDYA)'s financial standing, consider exploring this resource: Breaking Down IDEAYA Biosciences, Inc. (IDYA) Financial Health: Key Insights for Investors

IDEAYA Biosciences, Inc. (IDYA) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for evaluating the potential of any publicly traded company. For IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, several factors influence investor behavior and market perception. These include major shareholders' actions, recent market responses to ownership changes, and analysts' perspectives on the company's future.

Here's an exploration of these key aspects:

• Major Shareholders: Identifying key institutional investors and their holdings provides insights into the confidence level of sophisticated market participants.
• Recent Market Reactions: Analyzing how the stock market responds to changes in ownership or large investor moves can reveal prevailing sentiment.
• Analyst Perspectives: Examining analysts' opinions and ratings offers a professional assessment of the company's prospects.

As of April 2025, 98.29% of IDEAYA Biosciences stock is owned by institutional investors, highlighting significant institutional interest [3]. Major shareholders include [1]:

• FMR LLC with 14.81% [2]
• BlackRock Inc. with 9.57% [2]
• Vanguard Group Inc. with 5.80% [2]
• Federated Hermes Inc. with 5.78% [2]
• T. Rowe Price Associates, Inc. with 4.42% [2]

These institutions hold a substantial number of shares, reflecting their belief in the company's potential [4]. Tracking changes in their positions can offer clues about shifts in sentiment.

Recent market behavior indicates a turbulent period for IDEAYA Biosciences. As of April 7, 2025, the stock touched a 52-week low at $14.09 [11]. Over the past year, the stock price has declined by 65.4% [11]. However, analysts' price targets range from $27 to $65, suggesting potential upside despite the downturn [11].

Recent news and events that may have influenced market reactions include:

• Appointment of Joshua Bleharski as Chief Financial Officer, effective May 2025 [11].
• BTIG analysts reiterating a Buy rating with a price target of $62.00, supported by anticipated updates on the company's pipeline [11].
• IDEAYA's participation in investor relations events in April 2025, including the RBCCM Ophthalmology Conference and the Stifel Virtual Targeted Oncology Forum [7].

Analyst ratings provide valuable insights into the perceived potential of IDEAYA Biosciences. A consensus of 17 Wall Street analysts suggests a generally positive outlook:

• 94% of analysts recommend a 'Buy' rating [2].
• 5% of analysts recommend a 'Hold' rating [2].
• 0% of analysts recommend a 'Sell' rating [2].

Analysts actively covering IDEAYA Biosciences include [13]:

• BTIG (Justin Zelin)
• Cantor Fitzgerald (Li Watsek, Eric Schmidt)
• Citi (Yigal Nochomovitz)
• Goldman Sachs (Corinne (Jenkins) Johnson)
• Jefferies (Maury Raycroft)
• JP Morgan (Anupam Rama)
• RBC Capital Markets (Gregory Renza)

These analysts offer ongoing assessments that can influence investor sentiment and market movements.

IDEAYA Biosciences ended 2024 with approximately $1.1 billion in cash, cash equivalents, and marketable securities, which is expected to fund operations into at least 2028 [18]. Recent insider transactions show key executives acquiring shares, reflecting confidence in the company's future [9].

Here is a summary of recent insider transactions [9]:

Understanding the mission, vision, and core values of IDEAYA Biosciences can further inform investor perspectives. You can explore more about the company's foundational principles here: Mission Statement, Vision, & Core Values of IDEAYA Biosciences, Inc. (IDYA).

Overall, investor sentiment towards IDEAYA Biosciences is influenced by a combination of factors, including institutional ownership, market reactions to company-specific news, and analyst ratings. While the stock has faced challenges, positive analyst outlooks and strong financial positioning suggest potential for future growth.